Plus Therapeutics, Inc. (PSTV) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 1.03M | 1.37M | 1.4M | 1.39M | 1.06M | 1.41M | 1.46M | 1.28M | 1.68M | 1.31M | 1.24M | 1.85M | 506K | 151K | 73K | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | -2.93% | -3.19% | -4.05% | 8.68% | -36.85% | 7.54% | 17.42% | -31.01% | 231.42% | 769.54% | 1598.63% | - | - | - | - | - | - | - | - | -100% |
| Cost of Goods Sold | 109K | 92K | 86K | 86K | 181K | 232K | 232K | 202K | 186K | 182K | 188K | 188K | 187K | 287K | 123K | 165K | 137K | 117K | 18K | 94K |
| COGS % of Revenue | 10.6% | 6.73% | 6.16% | 6.19% | 17.09% | 16.43% | 15.93% | 15.79% | 11.09% | 13.86% | 15.16% | 10.14% | 36.96% | 190.07% | 168.49% | - | - | - | - | - |
| Gross Profit | 919K | 1.27M | 1.31M | 1.3M | 878K | 1.18M | 1.22M | 1.08M | 1.49M | 1.13M | 1.05M | 1.67M | 319K | -136K | -50K | -165K | -137K | -117K | -18K | -94K |
| Gross Margin % | 89.4% | 93.27% | 93.84% | 93.81% | 82.91% | 83.57% | 84.07% | 84.21% | 88.91% | 86.14% | 84.84% | 89.86% | 63.04% | -90.07% | -68.49% | - | - | - | - | - |
| Gross Profit Growth % | 4.67% | 8.05% | 7.11% | 21.08% | -41.11% | 4.33% | 16.35% | -35.35% | 367.4% | 931.62% | 2204% | 1109.7% | 332.85% | -16.24% | -177.78% | -75.53% | -53.93% | -24.47% | 76.92% | -150.81% |
| Operating Expenses | 8.04M | 7.02M | 5.79M | 2.84M | 4.41M | 5.08M | 5.02M | 4.77M | 4.79M | 4.99M | 4.3M | 3.16M | 5.04M | 5.44M | 5.04M | 4.96M | 3.79M | 3.52M | 3.48M | 2.48M |
| OpEx % of Revenue | 781.91% | 513.31% | 414.67% | 204.46% | 416.81% | 359.77% | 344.99% | 373.26% | 285.63% | 380.12% | 347.02% | 170.23% | 995.85% | 3600% | 6909.59% | - | - | - | - | - |
| Selling, General & Admin | 5.28M | 4.17M | 3.44M | 1.68M | 2.84M | 3.13M | 2.4M | 2.2M | 2.21M | 2.38M | 1.81M | 1.74M | 2.06M | 3.3M | 2.1M | 2.12M | 2M | 1.93M | 1.99M | 1.38M |
| SG&A % of Revenue | 513.81% | 304.9% | 246.46% | 121.01% | 268.08% | 221.39% | 164.63% | 172.24% | 131.96% | 181.19% | 145.97% | 93.64% | 406.32% | 2184.11% | 2875.34% | - | - | - | - | - |
| Research & Development | 2.87M | 2.94M | 2.44M | 1.25M | 1.76M | 2.19M | 2.86M | 2.77M | 2.76M | 2.79M | 2.49M | 1.42M | 2.98M | 2.14M | 2.94M | 2.83M | 1.78M | 1.6M | 1.49M | 1.11M |
| R&D % of Revenue | 278.7% | 215.14% | 174.37% | 89.64% | 165.82% | 154.82% | 196.29% | 216.81% | 164.76% | 212.8% | 201.05% | 76.59% | 589.53% | 1415.89% | 4034.25% | - | - | - | - | - |
| Other Operating Expenses | -109K | -92K | -86K | -86K | -181K | -232K | -232K | -202K | -186K | -182K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.12M | -5.74M | -4.48M | -1.54M | -3.54M | -3.9M | -3.8M | -3.7M | -3.3M | -3.86M | -3.25M | -1.49M | -4.72M | -5.57M | -5.09M | -5.12M | -3.93M | -3.64M | -3.5M | -2.58M |
| Operating Margin % | -692.51% | -420.04% | -320.83% | -110.65% | -333.9% | -276.2% | -260.92% | -289.05% | -196.72% | -293.98% | -262.18% | -80.37% | -932.81% | -3690.07% | -6978.08% | - | - | - | - | - |
| Operating Income Growth % | -101.33% | -47.23% | -17.98% | 58.4% | -7.18% | -1.04% | -16.86% | -148.12% | 30.11% | 30.73% | 36.18% | 70.9% | -20.22% | -53.03% | -45.58% | -98.83% | -58.37% | -7.25% | -150.64% | -9.48% |
| EBITDA | -7.01M | -5.68M | -4.4M | -1.42M | -3.35M | -3.67M | -3.57M | -3.5M | -3.11M | -3.79M | -3.06M | -1.3M | -4.53M | -5.29M | -4.97M | -4.96M | -3.79M | -3.52M | -3.41M | -2.48M |
| EBITDA Margin % | -681.91% | -415.87% | -314.67% | -101.94% | -316.81% | -259.77% | -244.99% | -273.26% | -185.63% | -289.03% | -247.02% | -70.23% | -895.85% | -3500% | -6809.59% | - | - | - | - | - |
| EBITDA Growth % | -108.94% | -54.99% | -23.24% | 59.46% | -7.77% | 3.35% | -16.45% | -168.43% | 31.33% | 28.19% | 38.38% | 73.72% | -19.64% | -49.97% | -45.69% | -99.72% | -58.54% | -6.76% | -158.88% | -9.88% |
| D&A (Non-Cash Add-back) | 109K | 57K | 86K | 121K | 181K | 232K | 232K | 202K | 186K | 65K | 188K | 188K | 187K | 287K | 123K | 165K | 137K | 117K | 87K | 94K |
| EBIT | -7.12M | -2.38M | -4.42M | 5.15M | -13.64M | -3.85M | -2.81M | 632K | -3.23M | -3.75M | -3.13M | -1.37M | -4.67M | -5.5M | -5.05M | -5.1M | -3.92M | -3.93M | -3.49M | -2.57M |
| Net Interest Income | 173K | 29K | 59K | 27K | -3.76M | -3K | 19K | -3.5M | 38K | 48K | 32K | 8K | -83K | -86K | -125K | -162K | -191K | -218K | -227K | -225K |
| Interest Income | 190K | 29K | 59K | 27K | 1K | 54K | 80K | 67K | 72K | 110K | 119K | 120K | 51K | 73K | 48K | 19K | 7K | 6K | 5K | 4K |
| Interest Expense | 17K | 0 | 0 | 0 | 3.76M | 57K | 61K | 3.57M | 34K | 62K | 87K | 112K | 134K | 159K | 173K | 181K | 198K | 224K | 232K | 229K |
| Other Income/Expense | 173K | 29K | 59K | 6.69M | -13.87M | -3K | 925K | 757K | 38K | 50K | 32K | 8K | -85K | -86K | -125K | -162K | -190K | -514K | -225K | -225K |
| Pretax Income | -6.95M | -5.71M | -4.42M | 5.15M | -17.4M | -3.9M | -2.87M | -2.94M | -3.26M | -3.81M | -3.22M | -1.48M | -4.8M | -5.66M | -5.22M | -5.28M | -4.12M | -4.16M | -3.72M | -2.8M |
| Pretax Margin % | -675.68% | -417.92% | -316.61% | 370.58% | -1643.15% | -276.42% | -197.39% | -229.87% | -194.45% | -290.18% | -259.6% | -79.94% | -949.6% | -3747.02% | -7149.32% | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -6.95M | -5.71M | -4.42M | 5.15M | -17.4M | -3.9M | -2.87M | -2.94M | -3.26M | -3.81M | -3.22M | -1.48M | -4.8M | -5.66M | -5.22M | -5.28M | -4.12M | -4.16M | -3.72M | -2.8M |
| Net Margin % | -675.68% | -417.92% | -316.61% | 370.58% | -1643.15% | -276.42% | -197.39% | -229.87% | -194.45% | -290.18% | -259.6% | -79.94% | -949.6% | -3747.02% | -7149.32% | - | - | - | - | - |
| Net Income Growth % | 60.08% | -46.37% | -53.9% | 275.2% | -433.61% | -2.44% | 10.72% | -98.38% | 32.13% | 32.66% | 38.32% | 71.94% | -16.74% | -36.17% | -40.14% | -88.64% | -51.32% | -15.83% | -115.51% | -52.26% |
| Net Income (Continuing) | -6.95M | -5.71M | -4.42M | 5.15M | -17.4M | -3.9M | -2.87M | -2.94M | -3.26M | -3.81M | -3.22M | -1.48M | -4.8M | -5.66M | -5.22M | -5.28M | -4.12M | -4.16M | -3.72M | -2.8M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.05 | -1.03 | -1.00 | -162.50 | -29750.00 | -16500.00 | -9250.00 | -6750.00 | -18750.00 | -21250.00 | -25000.00 | -14750.00 | -51750.00 | -64000.00 | -71250.00 | -89000.00 | -71250.00 | -100750.00 | -105250.00 | -93000.00 |
| EPS Growth % | 100% | 99.99% | 99.99% | 97.59% | -58.67% | 22.35% | 63% | 54.24% | 63.77% | 66.8% | 64.91% | 83.43% | 27.37% | 36.48% | 32.3% | 4.3% | 42.19% | 59.78% | 28.52% | 45.37% |
| EPS (Basic) | -1.05 | -1.03 | -1030.00 | 615.00 | -29750.00 | -12500.00 | -9250.00 | -11250.00 | -18750.00 | -21250.00 | -25000.00 | -14750.00 | -51750.00 | -64000.00 | -71250.00 | -89000.00 | -71250.00 | -101250.00 | -105250.00 | -93000.00 |
| Diluted Shares Outstanding | 6.65M | 3.11M | 42.97K | 8.37K | 583 | 236 | 314 | 430 | 173 | 180 | 129 | 100 | 93 | 1.05K | 73 | 59 | 57 | 484 | 35 | 30 |
| Basic Shares Outstanding | 6.65M | 3.11M | 4.3K | 1.94K | 583 | 315 | 314 | 260 | 173 | 180 | 129 | 100 | 93 | 1.05K | 73 | 59 | 57 | 484 | 35 | 30 |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |